Szot Matthew K's Form 4 filing
Cadrenal Therapeutics, Inc. (CVKD) · filed Oct 28, 2025
- Accession no.
- 0001213900-25-103147
- Filed
- Oct 28, 2025
- Trade date
- Oct 24-27, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $50.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Szot Matthew KCIK 0001401385 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2025 | Common Stock | SSaleDisposed | −1,800 | $13.99 | −$25,182 | 11,733 | Direct | |
| Oct 27, 2025 | Common Stock | SSaleDisposed | −1,800 | $13.99 | −$25,182 | 9,933 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.